Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-038592

CEO and CFO bought 2,500 shares at $7.97 ($19,925)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-10-26 Purchase +2,500 $7.97 $19,925 5,304,177 D
Open-market purchases · 2,500 sh · avg $7.97 · $19,925
Loading xslF345X05/ownership.xml…